Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.290
+0.040 (3.20%)
May 13, 2026, 4:00 PM EDT - Market closed
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $60.14 million as of May 13, 2026. Its market cap has decreased by -40.62% in one year.
Market Cap
60.14M
Enterprise Value
56.45M
1-Year Change
-40.62%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $60.14M, a decrease of -16.20%. That is a compound annual growth rate of -2.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 60.14M | -32.40% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImageneBio | 64.54M |
| Immutep | 62.77M |
| Impact BioMedical | 62.73M |
| MindWalk Holdings | 62.58M |
| Dogwood Therapeutics | 62.13M |
| Cingulate | 60.27M |
| BeyondSpring | 59.62M |
| Filana Therapeutics | 59.42M |